

Is Paroxetine in shortage in 2026? Get the latest update on Paroxetine availability, pricing, and what to do if you can't find your prescription.
If you take Paroxetine for depression, anxiety, or another condition, you may have heard reports about medication shortages — or experienced trouble finding it yourself. Drug shortages have become a recurring frustration for patients across the country, and it's natural to wonder: is Paroxetine affected?
Here's what you need to know about Paroxetine availability in 2026, including whether there's an active shortage, what's driving availability issues, and how to make sure you can keep getting your medication.
As of early 2026, Paroxetine is not on the FDA's official drug shortage list. The immediate-release generic tablets — which are the most commonly prescribed form — are manufactured by multiple companies including Apotex, Mylan, Teva, Zydus, and Aurobindo. Supply is generally stable.
However, some patients have reported spot shortages of certain formulations:
So while Paroxetine isn't in a national shortage, your individual experience may vary depending on your pharmacy, formulation, and location.
Several factors can make Paroxetine harder to find at your local pharmacy, even when there's no official shortage:
Active pharmaceutical ingredients are often manufactured overseas. Shipping delays, quality control issues at manufacturing plants, or raw material shortages can all create temporary gaps in supply. These disruptions may not rise to the level of a formal FDA shortage but can still leave your pharmacy temporarily out of stock.
Pharmacies stock medications based on demand. If your pharmacy doesn't have many patients on a particular Paroxetine dosage or formulation, they may not keep it on the shelf. This is especially true for Paxil CR, Brisdelle, and the oral suspension.
When fewer manufacturers make a particular formulation, any single production issue can have an outsized impact on supply. The immediate-release tablets have many manufacturers and rarely face shortages, while the CR formulation and suspension have fewer sources.
Prescribing rates for antidepressants and anti-anxiety medications have risen steadily. More patients seeking treatment means higher demand, which can strain supply for popular medications like Paroxetine. For a deeper dive into availability challenges, see why Paroxetine is hard to find in 2026.
One of the advantages of Paroxetine is that it's available as an affordable generic. Here's what you can expect to pay:
With insurance, generic Paroxetine is typically covered as a Tier 1 preferred generic, meaning your copay could be as low as $0 to $10. If cost is a concern, check out our complete guide on how to save money on Paroxetine.
While there aren't brand-new formulations of Paroxetine hitting the market, patients do have more options than ever for getting their medication:
If your pharmacy is out of Paroxetine, here's what to do:
For a detailed walkthrough, see our guide on how to find Paroxetine in stock near you.
Paroxetine remains widely available in 2026, and a national shortage is not currently in effect. However, certain formulations and dosages may be harder to find at specific pharmacies. The key is to plan ahead, use tools like Medfinder to check stock, and work with your doctor if you need to explore alternatives.
Above all, don't stop taking Paroxetine abruptly. It has a shorter half-life than other SSRIs and is known for causing discontinuation symptoms. If you're running low, take action early — your mental health is worth it.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.